Aurobindo pharmaceuticals recalls

    • Biogen

      The case against Stason Pharmaceuticals, Inc. in California has been dismissed, but the case against its partner Sawai USA, Inc. will proceed in Delaware. A trial has been set in the Delaware actions in December 2019 against all parties other than Banner Life Sciences LLC, and a trial has been set in the West Virginia action in February 2020.

    • Investors | Acadia Pharmaceuticals Inc.

      On July 24, 2020, the Company filed complaints against (i) Aurobindo Pharma Limited and its affiliate Aurobindo Pharma USA, Inc. and (ii) Teva Pharmaceuticals USA, Inc. and its affiliate Teva Pharmaceutical Industries Ltd., and on July 30, 2020, the Company filed complaints against (i) Hetero Labs Limited and its affiliates Hetero Labs Limited ...

    • Quarterly Results | Johnson & Johnson

      Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson & Johnson arising out of the use of RISPERDAL®, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism.

    • [DOC File]Second section

      https://info.5y1.org/aurobindo-pharmaceuticals-recalls_1_84b1cb.html

      Mbeki and AIDS _____ ANTHONY BRINK. Open books Publishing info. If ever there was in the world a warranted and proven history, it is that of vampires.

    • [DOCX File]Executive summary - Department of the Prime Minister and ...

      https://info.5y1.org/aurobindo-pharmaceuticals-recalls_1_2f9456.html

      The compliance costs for stock recalls has not been estimated as the assumed implementation timeframe should provide adequate time for turn-over of stock across the supply chain. PGA have indicated that the codeine products have a short shelf life (i.e. rapid turnover) within pharmacies. Over 1 month, PGA personal communication, September 2016

    • Nektar Therapeutics

      AMITIZA® is marketed by Mallincrodt Pharmaceuticals and Takeda. There is also a subcutaneous treatment and an oral treatment known as RELISTOR® which is marketed by Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc., which previously acquired Salix) under a license from Progenics Pharmaceuticals, Inc.

    • Investor and Media Overview | Endo International plc

      Beginning in April 2018, PSP LLC and PPI received notice letters from Eagle Pharmaceuticals, Inc., Sandoz, Inc., Amphastar Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC, American Regent, Fresenius, Dr. Reddy’s Laboratories, Inc. and Aurobindo Pharma Limited advising of the filing by such companies of ANDAs/New Drug Applications (NDAs) for ...

    • investor.lilly.com

      Other pharmaceuticals, including: ... (cGMP) regulations for pharmaceutical products can lead to product recalls and seizures, interruption of production leading to product shortages, and delays in the approvals of new products pending resolution of the cGMP issues. We are now operating under a Corporate Integrity Agreement with the Office of ...

    • Quarterly Results | Johnson & Johnson

      In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) and Amneal Pharmaceuticals LLC (Amneal), each of whom filed an ANDA seeking approval to market a generic version of OPSUMIT ® before ...

    • Analysts | Mallinckrodt

      Our competitors vary depending upon therapeutic and product categories. Major competitors of our Specialty Generics products include Rhodes Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Amneal Pharmaceutical Ltd., Noramco, Inc. and Johnson Matthey plc, among others.

    • investor.lilly.com

      Sicor Pharmaceuticals, Inc. (Sicor), Mayne Pharma (USA) Inc. (Mayne), and Sun Pharmaceutical Industries Inc. (Sun) each submitted ANDAs seeking permission to market generic versions of Gemzar prior to the expiration of our relevant U.S. patents (compound patent expiring in 2010 and method-of-use patent expiring in 2013), and alleging that these ...

    • Agile Therapeutics

      On February 26, 2021, Amneal Pharmaceuticals, Inc. announced that it had received approval by the FDA for Zafemy, a second generic version of Ortho Evra. Additionally, several generics manufacturers currently market and continue to introduce new generic contraceptives, including Sandoz, Glenmark, Lupin, Amneal, Mylan, Aurobindo, Xiromed, and ...

    • [DOC File]Exercices corriges PDF

      https://info.5y1.org/aurobindo-pharmaceuticals-recalls_1_04c4cd.html

      Footnote II ... Human "Divinity" in Hinduism From Sri Chinmoy, Indian spiritual teacher and philosopher who spent twenty years in spiritual practice at the Sri Aurobindo Ashram in South India before emigrating to the U.S. in 1964... [Emphasis Added] "...man has to learn that he has only one thing to do, and that is to discover and uncover.

    • Nektar Therapeutics

      Table of Contents. UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549 ...

Nearby & related entries:

To fulfill the demand for quickly locating and searching documents.

It is intelligent file search solution for home and business.

Literature Lottery

Advertisement
Hot searches

©2024 5y1.org, Inc. All rights reserved.